Chemokine and Chemokine Receptor Expression in Acute Allograft Rejection (AAR): An Overview
摘要
There are now extensive data and studies on the observation of many chemokine and chemokine receptors in human renal transplantation that show increased expression in acute allograft rejection (AAR). The chemokine receptor CXCR3 has been established as a significant immunological component in acute renal allograft rejection. In patients who develop AAR, circulating CXCR3 expression is significantly upregulated (by day 3 posttransplantation). CXCR3+, activated T-cells are present in the cellular infiltrates in acute renal allograft rejection. CXCR3+ T-cell infiltrates are localised to sites of high IP-10/CXCL10 expression. Published data vary from 30% to 90%. This chapter looks to provide a retrospective overview of chemokine and chemokine receptor expression in AAR in the context of human renal transplantation and transplant immunobiology. This chapter will additionally offer an overview of how social media organisations, that is, (1) The Renal Patient Support Group (RPSG) (since 2009) and (2) the Kidney Disease and Renal Support (KDARs) Group for Kids (since 2014) look to encourage healthcare inclusivity, to bridge healthcare disparities and to decolonise essential topics in human transplant immunobiology and across laboratory practices, and to enhance Patient and Public Involvement (PPI). Laboratory investigations have informed that in human renal transplantation, there are alternative pathways that promote the development of a pro-trafficking phenotype of T-cells in recipients that have received anti-CD25. The hypothesis was addressed by using a T-cell culture system to analyse the effects of anti-CD25 on the expression of CXCR3 and other significant chemokine receptors on the surface of T-cells. Additionally, literature informs how online spaces have allowed patients with long-term conditions (LTCs) to access information through websites, portals, and patient-centred organisations. Investigation into the role of chemokines and mediation of AAR research is still challenging, primarily because of the unsatisfactory nature of laboratory representations of AAR. Retrospective research indicates that chemokines have direct effects not only on leukocyte recruitment but also on the recruitment, proliferation, and activation of vascular smooth muscle cells and other nonhaematopoietic cells. CXCR3 induction and IP-10 mRNA has been associated with AAR aligned to human renal transplantation and transplant immunobiology. Immunobiology relating laboratory investigations and transplantation can be difficult to appreciate. However, social media platforms as ‘space’ have importance, prompt inclusive healthcare practices. The RPSG and KDARs invite patients, health professionals, and researchers to codevelop interlinked and inclusive healthcare, bridging clinical and pathology practices. Both RPSG and KDARs have prompted collaborative practice, highlighting the importance of patient and health professional codeveloping efforts. The importance of decolonisation of serological immunobiological investigations is not stressed amongst current literature.